Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRIANA: Primary Angioplasty vs Thrombolysis in Elderly AMI
NCT00257309Phase 4Terminated
- Sponsor
- Sociedad Española de Cardiología
- Start
- Apr 2005
- Primary completion
- Feb 2008
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tenecteplase in acute myocardial infarction (AMI) (2 arms), sponsored by Sociedad Española de Cardiología. Primary endpoint: Incidence of the aggregate of death of any cause, reinfarction or disabling stroke at 30 days. Started Apr 2005; status: terminated.
02
Drugs
tenecteplase
03
Conditions
acute myocardial infarction (AMI)
Beyond the preview
Go deeper on NCT00257309.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00257309.